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Abstract: Chronic stress is a known contributing factor to the development of drug and alcohol
addiction. Animal models have previously shown that repeated forced swim stress promotes escalated
alcohol consumption in dependent animals. To investigate the underlying molecular adaptations
associated with stress and chronic alcohol exposure, RNA-sequencing and bioinformatics analyses
were conducted on the prefrontal cortex (CTX) of male C57BL/6J mice that were behaviorally tested for
either non-dependent alcohol consumption (CTL), chronic intermittent ethanol (CIE) vapor dependent
alcohol consumption, repeated bouts of forced swim stress alone (FSS), and chronic intermittent
ethanol with forced swim stress (CIE + FSS). Brain tissue from each group was collected at 0-h,
72-h, and 168-h following the final test to determine long-lasting molecular changes associated with
maladaptive behavior. Our results demonstrate unique temporal patterns and persistent changes
in coordinately regulated gene expression systems with respect to the tested behavioral group.
For example, increased expression of genes involved in “transmitter-gated ion channel activity” was
only determined for CIE + FSS. Overall, our results provide a summary of transcriptomic adaptations
across time within the CTX that are relevant to understanding the neurobiology of chronic alcohol
exposure and stress.
Keywords: alcohol drinking; dependence; stress; RNA-Sequencing; prefrontal cortex; mouse
1. Introduction
The etiology of neuropsychiatric disorders is multifaceted, characterized by the continual
interaction of biological and environmental forces. Stress is a major pervasive source of environmental
pressure influencing biological control of mental and emotional well-being. Maladaptive responses
to acute and chronic stress can facilitate persistent allostatic mood states of behavior (the physical
and psychological toll paid to maintain stability in the face of stress exposure). Such stress-induced
imbalances in positive- and negative-reinforcement of behavioral control contributes to the development
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of substance use disorders, including alcohol use disorder (AUD) [1]. Studying the neurobiological
adaptations that occur in relation to stress and substance use (e.g., alcohol consumption) is
important for understanding the pathogenesis of individual neuropsychiatric disorders and comorbid
disease phenotypes.
Transcriptional reprogramming of gene expression within the central nervous system (CNS)
has been proposed as a fundamental molecular process underlying repeated exposure to substances
of abuse [2]. Examination of human postmortem brain tissue and animal models for AUD have
demonstrated biologically coordinated changes in gene expression throughout several cell-types and
areas of the CNS. Specific groups of evolutionarily conserved protein-coding and non-coding gene
expression networks are associated with lifetime consumption of alcohol [3,4], suggesting chronic
neuroadaptations proportional to substance use. Despite the valuable contributions of postmortem
human brain to understanding the neurobiological impact of long-term alcohol use [5], not all of the
psychological and pathophysiological measures are appropriately measured or rigorously controlled
in human samples. Animal models provide essential translational tools for investigating the direct
effects of alcohol and interaction with environmental variables, such as repeated stress, withdrawal,
and periods of abstinence.
The rodent model of repeated forced swim stress (FSS) is a chronic test of inescapable stress,
inducing a negative state of coping behavior, a prolonged period of poor performance due to
uncontrollable and adverse conditions [6,7]. In a mouse (C57BL/6J) model of chronic intermittent
ethanol (CIE) vapor exposure, known to affect tolerance and increase ethanol consumption [8,9],
FSS causes robust increases of ethanol consumption in mice with a history of CIE exposure [10,11].
The added component of FSS in CIE mice is associated with greater amounts of alcohol consumption
than either a no stress exposure or a model of repeated social defeat stress and does not affect more
moderate levels of alcohol consumption in non-dependent mice [10]. Escalation of alcohol consumption
in dependent mice via the interaction of FSS suggests, at least in part, convergent biological pathways
activated by chronic stress and alcohol [11].
In an effort to better understand the shared and nonshared molecular adaptations in response to
FSS and CIE, the current investigation examined transcriptome-wide alterations in gene expression
across the medial prefrontal cortex (CTX), a brain-region known to be involved in decision-making
and compulsive alcohol consumption [12]. The combined effect of FSS and CIE on changes in global
gene expression that occur within the CTX is currently unknown. Prior studies have demonstrated
brain-regional and temporal changes in gene expression for male C57BL/6J mice with a history of
CIE [13,14], providing supportive evidence for widespread CNS plasticity following chronic alcohol
exposure on the CTX and other brain-regions. Our results demonstrate conditional long-term changes
in CTX gene expression for behavioral models of alcohol consumption and chronic inescapable stress.
The combined effect of this measure of stress and alcohol consumption is essential for continued
adaptations in CNS plasticity.
2. Materials and Methods
Animal Model: Adult male C57BL/6J (B6J) mice, 10 weeks of age, were purchased from Jackson
Laboratories (Bar Harbor, ME) and individually housed under a 12-h light/dark cycle (lights on at
8:00 a.m.). Animals were given ad libitum access to food (Teklad rodent diet) and water in a temperature
and humidity controlled AAALAC-accredited facility at the Medical University of South Carolina.
All procedures were approved by the Institutional Animal Care and Use Committee and conducted in
accordance with the NIH Guide for the Care and Use of Laboratory Animals.
Procedure: Mice were evaluated in the CIE-FSS Drinking model, as illustrated in Figure 1. Briefly,
mice were first trained to drink 15% (v/v) ethanol with access for 1 h/day starting 3 h after lights off. Once
stable baseline intake was established (~3 weeks), mice were separated into four groups (equated for
baseline level of alcohol intake): non-dependent alcohol consumption (CTL), FSS, CIE, and CIE + FSS.
Mice in the CIE and CIE+FSS groups received CIE vapor exposure in inhalation chambers (16 h/day
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for 4 days), as detailed below. Mice in the remaining groups (CTL and FSS) were similarly handled but
maintained in air inhalation chambers. As in our previous work [10,11], all groups received pyrazole
(1 mmol/kg) injections (ip) immediately prior to being placed into inhalation chambers (to stabilize BEC
in CIE and CIE + FSS groups). Limited access drinking sessions were suspended during inhalation
exposure. After a 72-h abstinence period, drinking test sessions resumed for 5 consecutive days under
the same limited access conditions as before. This pattern of weekly chronic intermittent ethanol (or
air) exposure alternated with weekly limited access drinking sessions was repeated for 4 cycles (Test
Cycles 1–4) (Figure 1). Mice in the FSS and CIE + FSS groups experienced 10 min of forced swim stress
(FSS) 4 h prior to each of the test drinking sessions, as detailed below. The remaining mice (CTL and
CIE groups) remained in their home cage undisturbed. As indicated in Figure 1, mice were sacrificed
after a fifth and final CIE (or air control) cycle, either immediately (0-h), 72 h, or 7 days after the last
CIE (or air) exposure. Mice were decapitated, and whole brains were immediately snap-frozen.
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BEC. Housing conditions were similar to those in the colony room. Blood samples (40 µL) were 
obtained from the retro-orbital sinus with heparinized capillary tubes during each CIE cycle of 
exposure. Blood samples were centrifuged, and plasma was processed in an Analox Instrument 
analyzer (Analox Instruments USA, Lunenburg, MA, USA), with blood ethanol levels expressed as 
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Forced Swim: Mice were placed in a glass cylinder (20-cm diameter × 40-cm tall) filled with 23–
25°C water for 10 min [10,11]. 
Design and Data Analysis: Voluntary ethanol intake in grams per kilogram of body weight was 
the main behavioral dependent variable under analysis. Daily intake values were averaged over the 
last five days of baseline and the five days of each test cycle. Less than 1% of the data points obtained 
were aberrant due to leaks. Those values were replaced by the weekly mean value for that particular 
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Figure 1. Experimental design for the chronic intermittent ethanol–forced swim stress (CIE-FSS)
drinking model. The study design yielded 4 experimental groups: non-dependent alcohol consumption
(CTL), CIE, FSS, and CIE + FSS. The “*” represents the time of sacrifice (0-h or 72-h or 168-h) after the
last CIE/Air exposure. Only the last 5 days of baseline are represented in this scheme, and the red
triangles indicate stress (FSS) exposure. A separate group of naïve mice were sacrificed and used as a
common reference for gene expression analysis.
CIE Exposure: Mice in the CIE and CIE + FSS groups received chronic intermittent ethanol
(CIE) vapor exposure in inhalation chambers (16 h/day for 4 days), while CTL and FSS mice were
similarly handled but exposed to air in control chambers. CIE exposure was administered in inhalation
chambers according to procedures previously described [8–10]. Briefly, mice were placed in Plexiglas
inhalation chambers (60 W × 60 L × 36 H cm) and exposed to ethanol vapor at levels set to yield
stable blood ethanol concentrations (BEC) in C57BL/6J mice in the range of 175–225 mg/dL. Separate
sets of inhalation chambers were used for animals to better control vapor concentrations that yielded
similar BEC. Housing conditions were similar to those in the colony room. Blood samples (40 µL)
were obtained from the retro-orbital sinus with heparinized capillary tubes during each CIE cycle
of exposure. Blood samples were centrifuged, and plasma was processed in an Analox Instrument
analyzer (Analox Instruments USA, Lunenburg, MA, USA), with blood ethanol levels expressed
as mg/dL.
Forced Swim: Mice were placed in a glass cylinder (20-cm diameter × 40-cm tall) filled with
23–25 ◦C water for 10 min [10,11].
Design and Data Analysis: Voluntary ethanol intake in grams per kilogram of body weight was the
main behavioral dependent variable under analysis. Daily intake values were averaged over the last
five days of baseline and the five days of each test cycle. Less than 1% of the data points obtained were
Brain Sci. 2020, 10, 275 4 of 15
aberrant due to leaks. Those values were replaced by the weekly mean value for that particular subject.
Data were analyzed by ANOVA, with group (CTL, FSS, CIE, or CIE + FSS) and time of brain collection
(0-h, 72-h, or 7 days) as between-subject factors and phase (baseline, Tests 1–4) as a repeated measure
(n = 7–10/group). BECs were also analyzed by ANOVA, with group and exposure cycle as the main
factors. For both analyses, significant main effects and interactions were further analyzed using the
Newman-Keuls test for paired comparisons. Statistica 13 (TIBCO Software Inc., Palo Alto, CA, USA)
was used for these data analyses. The experimental design is illustrated in Figure 1.
Brain Tissue Dissection and RNA Isolation: Frozen brains were embedded in a plastic mold containing
ice-cold optimal cutting temperature compound (OCT) and quickly frozen in an isopentane/powdered
dry ice system. A Microm HM550 cryostat (Thermo Scientific, Ontario, CA, USA) was used for
sectioning at a thickness of 300 µm. Micropunches were bilaterally collected from mouse prefrontal
cortex (CTX 1.5 mm; Bregma 2.96mm–1.98mm) and individually pooled per mouse for total RNA
extraction at each of the timepoints and from a naive subjects group. Total RNA was isolated using
the MagMAX-96 Total RNA Isolation kit (#1839 Thermo Fisher Scientific Inc., Rockford, IL, USA) and
DNAse-treated according to the manufacturer’s instructions (#1906, Thermo Fisher Scientific Inc.,
Rockford, IL, USA). Quality and quantity of isolated total RNAs were characterized with a nanodrop
8000 spectrophotometer (Thermo Fisher Scientific, Rockford, IL, USA; 260/280 and 260/230 ratios),
Agilent 2200 TapeStation Instrument (Agilent Technologies, Santa Clara, CA, USA; RNA-integrity
numbers ranged between 9–10), and Qubit fluorometric quantitation (Thermo Fisher Scientific).
An aliquot of 400-ng total RNA (based on Qubit) was used for RNA-sequencing.
RNA-Sequencing and Bioinformatics Analyses: Isolated total RNA from mouse CTX was submitted to
the Genomic Sequencing and Analysis Facility at The University of Texas at Austin. Sequencing libraries
were constructed using a 3’ Tag-based approach (TagSeq), targeting the 3’ end of RNA fragments [15]
from ~16 ng/µL of each RNA sample. This tag-based approach is a cost-efficient alternative to
whole-transcriptome RNA sequencing, comparable with respect to accuracy and quantification of
detected transcripts [16]. Samples were sequenced on the HiSeq 2500 (Illumina) platform with a read
depth of approximately 7.6 million reads (single-end 100 bp reads; 4.6 million high quality reads
per sample after trimming). A total of 95 samples were included with an average of 7.6 million
reads per sample. There were 3.1 million uniquely mapped reads after mapping (91% mapping).
RSeQC read distribution identified ~ 980K 3’UTR exon reads that were 32% of uniquely mapped reads.
TagSeq detected a total of 56,350 transcripts. On average, 38,000 transcripts per sample were detected,
representing ~22,000 protein coding genes. Sequencing sample size (n) for each group: CIE+FSS: 000h
(n = 7), 072h (n = 6), and 168h (n = 7); CIE: 000h (n = 8), 072h (n = 5), and 168h (n = 9); FSS: 000h (n = 9),
072h (n = 7), and 168h (n = 10); and CTL: 000h (n = 9), 072h (n = 8), and 168h (n = 10). Duplicated
reads (5’) sharing the same degenerate header and the first 20 bases of the sequence was trimmed off
fastq files. Read quality was assessed using MultiQC (version 1.7). Reads were mapped to the mouse
reference genome (Gencode GRCm38.p6 release M22) using a STAR (version STAR_2.5.4b) aligner [17].
Read distribution of bam files over reference genomic features was evaluated with RSeQC (version
3.0.0) [18]. Raw counts were quantified using HTSeq (version 0.11.2). ERCC RNA Spike-In Mix 1
(Thermo Fisher Scientific, Rockford, IL, USA; Part no 4456740) was used to assess platform dynamic
range and lower limit detection.
Differential Gene Expression and Time-Course Cluster Analysis: The R (version 3.5.1) package DESeq2
(version 1.22.2) [19] was used to identify changes in expression across different levels with a likelihood
ratio test (LRT) using the DESeq function. To identify changes in gene expression from a common
baseline, individual groups and timepoints were initially compared against naive subjects. A nominal
p-value less than or equal to 0.05 was selected to ascertain shared and nonshared changes in gene
expression among the groups and timepoints with respect to affected biological categories and pathways.
The full DESeq model of ~Group + Time + Group:Time, versus the reduced model ~Group + Time, was
used to identify transcriptome patterns using the clustering tool degPatterns from the “DEGreport” R
package (version 1.19.1). The function was run using the default parameters, except that the produced
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clusters were allowed to contain a minimum of one gene representative (minc = 1). This produced
clusters (n = 14) based on similar profiles. In order to establish a set of stringent gene expression
clusters according to both group and time, statistically significant changes were limited to genes less
than or equal to a false discovery rate of 5%.
Gene Ontology, Molecular Pathway, and Cell-Type Analysis: Differentially expressed genes were
analyzed for enrichment of canonical gene ontologies and molecular pathways using the bioinformatic
tool Enrichr [20,21]. Reported ontological categories and pathways were limited to those consistently
altered across all timepoints within each of the separate experimental groups (p < 0.05). Differentially
expressed genes (Group + Time) were compared to genes with 10-fold higher expression in either
murine neurons, oligodendrocytes, astrocytes, and microglia [22] to determine the overrepresentation
of the major CNS cell-types using a Fisher’s exact test (p < 0.05).
3. Results and Discussion
3.1. Blood Ethanol Concentration during CIE Exposure Cycles
Mice were exposed to ethanol vapor concentrations set to produce BEC around 200 mg/dL.
ANOVA indicated a significant group × cycle interaction (F(4,188) = 2.75; p < 0.05), and post-hoc
comparisons indicated that mice in the CIE + FSS mice exhibited higher BEC than CIE mice during
Cycles 2 and 3 of intermittent ethanol vapor exposure (Figure 2). Importantly, blood ethanol levels
were similar between CIE and CIE + FSS groups during the last two exposure cycles (Cycles 4 and
5) before brain samples were collected (Figure 2). Additionally, BECs were similar between CIE and
CIE+FSS groups at the time brains were collected immediately after the last 16-hr vapor exposure
(F(1,15) = 0.28; p = NS) (Figure 2).
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Figure 2. Blood ethanol concentrations (BEC) in mg/dL registered during each CIE exposure cycle and
at the 0-h timepoint of tissue collection for the CIE and CIE + FSS groups. BECs were different between
these groups only during exposure Cycles 2 and 3 (*).
3.2. Voluntary Ethanol Intake
The ANOVA indicated significant main effects of group (F(3,97) = 64.07; p < 0.0001) and phase
(F(4,388) = 70.82; p < 0.001) and a significant interaction between these factors (F(3,388) = 23.05;
p < 0.0001). Importantly, the time of brain collection did not have a significant effect (F(2,97) = 0.24)
and did not have a significant interaction with the other factors under analysis. Post-hoc comparisons
based on the significant group × phase interaction indicated that mice in the CIE and CIE + FSS groups
consumed more ethanol during all test cycles compared to CTL mice within each test cycle and their
own baseline (* in Figure 3). This analysis also showed that mice in the FSS group had a lower intake
level during Test 3 compared to their own baseline (ˆ in Figure 3). Importantly, mice in the CIE + FSS
evidenced significantly higher levels of intake compared to CIE mice during test Cycles 2, 3, and 4 (# in
Figure 3).
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Figure 3. Ethanol intake in g/kg during the baseline and each test cycle after CIE or air exposure for the
CTL, FSS, CIE, and CIE + FSS groups. CIE and CIE + FSS mice showed a significantly higher level
of voluntary ethanol intake when compared to CTL mice and their own baseline (*). Mice in the FSS
group drank less ethanol during Test 3 compared to their own baseline. Mice in the CIE + FSS group
consumed the most ethanol compared to all the other groups during Test Cycles 2–4 (#).
3.3. Overview of Differential Gene Expression
Stress and addiction to alcohol, as well as other substances of abuse, are interlinked components
of mental health. Identifying the shared and unshared biological systems impacted for these conditions
represents an important step in understanding the pathophysiology of diseases associated with AUD
and stress. The current studies sought to test the hypothesis that nondependent alcohol consumption
(CTL), chronic intermittent ethanol (CIE) vapor-induced dependence, repeated forced swim stress (FSS),
and the combination of CIE and FSS produce distinct transcriptomic signatures within the prefrontal
cortex, a critical brain-region involved in stress and alcohol addiction [23,24]. RNA-seq analysis was
conducted on total RNA isolated from the medial prefrontal cortex (referred to as CTX throughout
the manuscript) to identify transcriptome-wide gene expression changes in four treatment groups
compared to naive subjects: CTL, CIE, FSS, and CIE + FSS. In order to characterize temporal patterns
of transcriptomic responses underlying the allostatic load for each behavioral condition, cortical tissue
was collected at 0 h, 72 h, and 168 h following the final experimental session (Figure 1). Investigating
the transcriptome response of multiple timepoints is required for determining early, intermediate, and
long-lasting molecular adaptations that occur in animal models of human disease. The biological
contribution from each of these timepoints may be important mediators in the development and
continuation of abnormal behavioral responses.
We identified 1651–4322 differentially expressed genes with nominal p-values less than or equal
to 0.05. These changes vary in a Cohen’s d effect size between −6.57 and 7.65, with a mean absolute
effect size of 1.56. In general, the number of significant expression changes decreased as a function of
time (0 h > 72 h > 168 h; Figure 4A). Across all treatment groups and timepoints, there was a greater
number of upregulated compared to downregulated genes. Each of the separate treatment groups
exhibited mostly unique transcriptome signatures across each of the examined timepoints (Figure 4B).
Time-dependent patterns of gene expression changes shared within each treatment group ranged
from 24% (FSS 0 h & 168 h) to 57% (FSS 0 h & 72 h). This degree of overlapping changes was generally
stronger for increased versus decreased gene expression (Figure 5). Although many alterations in gene
expression were unique across treatment groups and timepoints, the considerable overlap ranging
from 204–488 genes may suggest that opportunity to voluntarily drink ethanol (albeit at different
levels in each of the independent treatment groups) induced unique long-lasting alterations to the CTX
transcriptome. However, it is also possible that compared to naïve subjects, the degree of overlapping
changes in the gene expression may be partially due to the alcohol dehydrogenase inhibitor pyrazole.
In concordance with our previous microarray study from the CTX on time-dependent (0-h, 8-h, and
120-h) gene expression changes due to repeated chronic intermittent ethanol (CIE) vapor exposure [13],
there were 1800 overlapping genes also identified in the current time-course. As a result of the technical
advantages of RNA-seq compared to microarrays, as well as a different time trajectory collected
here, the current study was powered to detect up to 4322 differentially expressed genes for CIE.
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Figure 4. Summary of differential gene expression results for the medial prefrontal cortex (CTX) based
on comparison to naïve subjects. (A) Bar plots of the number of differentially expressed genes at
timepoints 0 h, 72 h, and 168 h. Increased gene expression shown in dark grey, and decreased gene
expression shown in white. (B) Venn-diagrams showing the four-way overlap of all differentially
expressed genes for timepoints 0 h, 72 h, and 168 h. Each of the respective behavioral groups are
indicated by a different color: CTL = light grey, CIE = yellow, FSS = blue, and CIE + FSS = green.
Similar to previous studies on time-dependent changes in gene expression [13,14], our results
demonstrate short- and long-term effects on coordinately regulated biological systems by CIE
(Supplementary Table S1). For example, brain-derived neurotrophic factor (Bdnf ), which in the
present study has decreased expression in the CTX of CIE mice at 0 h and 72 h, is an important nerve
growth factor involved in CNS plasticity and escalation of alcohol consumption [25,26]. Increased
expression of Bdnf in the prefrontal cortex of adult male C57BL/6J mice reduces CIE-induced alcohol
consumption [27]. CIE decreases Bdnf expression in the medial prefrontal cortex of adult male C57BL/6J
mice and increases the expression of microRNA miR-206 [28]. This microRNA selectively suppresses
Bdnf expression in the medial prefrontal cortex of alcohol-dependent rats [29]. Our analysis shows CIE
dependent gene expression is consistently overrepresented for miR-206 gene targets at the 0-h, 72-h,
and 168-h timepoints (Supplementary Table S1). None of the other tested behavioral groups (i.e., CTL,
FSS, and CIE + FSS) consistently altered the expression of known miR-206 targets across all of the
examined timepoints. CIE may be an experimental factor involved in the regulation of the expression
of specific noncoding (e.g., miR-206) and protein-coding transcripts controlling distinct aspects of
excessive alcohol consumption and addictive behavior. Additionally, the current study demonstrated
shared, and nonshared, changes in gene expression for alcohol dependence and withdrawal (CIE) with
non-dependent alcohol consumption and forced swim stress (Figure 5).
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Figure 5. Venn-diagrams within each behavioral group across the examined time-course. Shown are the
results for all differentially expressed genes (left), increased gene expression (middle), and decreased
gene expression (right) for each of the respective behavioral groups. CTL = light grey, CIE = yellow,
FSS = blue, ands CIE + FSS = green.
Chronic uncontrollable stress is a significant source of physical and psychological strain. Genotype
differences between different strains of mice influences measures of stress and adaptive behavior,
with C57BL/6J mice demonstrating greater baseline immobility and the least amount of experimental
variation in the forced swim test among 11 tested strains of mice [25]. Using the repeated forced swim
stress (FSS) mouse behavior model, our transcriptome analysis indicated this stress exposure produces
an immediate and prolonged increase in genes related to steroid-related transcription and epigenetic
control of gene expression (Table 1). Dysregulation of the HPA-axis due to environmental stressors
disrupts the proper secretion of corticosteroids, causing an imbalance in signaling processes and
structural changes in several brain regions, including the prefrontal cortex [26]. The prefrontal cortex
is an essential component of the neurocircuitry involved in decision-making and providing negative
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feedback to the stress-evoked activation of the HPA-axis [27–29]. Aberrant levels of corticosteroids are
capable of distorting dopaminergic function in mesocortical neurons through the alteration of DNA
methylation [30]. Inhibition of dopaminergic neurons in mice adversely affects the motivated behavior
using the forced swim test without affecting the generalized locomotor activity [31]. Repeated FSS
exposure could establish a physiological state of anhedonia, which when combined with CIE, gives rise
to a selective upregulation in expression of genes involved in the “response to dopamine” (GO:1903350;
Supplementary Table S1).
The Bioconductor package DEGreport includes a degPatterns function that uses a hierarchical
clustering approach based on pairwise correlations to identify sets of genes with consistent patterns
of expression as a function of both time and treatment group (Supplementary Table S2). We used
degPatterns to identify distinct temporal patterns of expression across treatment groups. The list
of 292 statistically significant genes (padj < 0.05) identified by DESeq2 was used as input for the
analysis. A total of 14 clusters (distinct expression patterns) were identified. The number of genes
per cluster ranged from 2–70 genes per cluster (Figure 6). The largest cluster (Cluster 1 of Figure 6
and Supplementary Table S2) shows a transient increase at 0 h followed by a stepwise decrease in the
expression of genes with time following CIE or CIE + FSS treatments. The neuro-immuno-responsive
interferon genes Irf7, Ifit1, Ifit3, and Ifitm3 represented in Cluster 1 are temporarily increased in the CTX,
gradually returning to baseline levels. This is accompanied by the same pattern of expression change in
other genes such as the enzyme Plat and neuropeptide Vip. Vasoactive intestinal peptide (Vip) is known
to selectively activate interferon alpha/beta synthesis in glial cells [32], suggesting a potential short-term
modulatory role of the neuroimmune system following CIE. Cluster 3 (Figure 6 and Supplemental Table
S2) shows a similar trend represents genes like Ctss and B2m, which were identified as novel genetic
determinants of complex behavioral traits and neuroimmune signaling in the regulation of alcohol
consumption [33]. Another prominent pattern of expression includes genes that increase as a function of
time in CIE and CIE + FSS groups. For example, Cluster 7 (Figure 6 and Supplemental Table S2) includes
the alcohol responsive genes Pde4a and Gabbr2. Phosphodiesterases regulate immune pathways, and
PDE4, in particular, has been implicated in alcohol and substance use disorders. The PDE4 inhibitor
rolipram has been shown to reduce ethanol intake and preference in mice [34], and apremilast produces
stable decreases in voluntary ethanol consumption [35]. Additionally, preclinical and clinical data
suggest a therapeutic potential for ibudilast, a more general PDE inhibitor [36,37]. In contrast, Cluster
10 (Figure 6) shows a striking stepwise decrease in the expression of 8 genes: Cbln4, Cdhr1, Rab37, Calb2,
Traf7, Doc2g, Eomes, and Cers2 across timepoints only in the CIE + FSS treatment. These genes are
unchanged in clusters from the other treatment groups. Cers2 shows enrichment in molecular pathways
and gene ontogenies for sphingolipid metabolism. The sphingolipid system has been implicated
as a molecular mechanism involved in alcohol’s self-medicating effects on innate depression [38].
In addition, Cers2 is known to be involved in the regulation of axon regeneration, which may be
important after long-term withdrawal from alcohol. Together, these novel results implicate specific
genes associated with combined alcohol dependence and stress.
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Table 1. Gene ontology analysis of molecular function for (A) increased and (B) decreased differential gene expression, showing canonical groups that are consistently
altered across time and uniquely regulated within each behavioral group (CTL, CIE, FSS, and CIE + FSS). The number of genes represent the union of significant genes
in that behavioral group and canonical molecular function across time. Results are significantly overrepresented (p < 0.05), uniquely with respect to an individual
group and timepoint. CTL: non-dependent alcohol consumption, CIE: chronic intermittent ethanol, and FSS: forced stress swim.
Group Name 000-h 072-h 168-h Number of Genes
(A)
AIR RNA polymerase II regulatory region sequence-specific DNA binding (GO:0000977) 5.09E−05 4.86E−02 1.39E−03 89
AIR kinase binding (GO:0019900) 3.60E−04 1.99E−02 3.50E−03 84
AIR RNA polymerase II regulatory region DNA binding (GO:0001012) 4.78E−04 2.16E−02 2.48E−03 45
AIR SUMO binding (GO:0032183) 9.12E−04 2.34E−02 1.55E−02 6
AIR phosphoprotein phosphatase activity (GO:0004721) 1.55E−03 6.64E−03 4.21E−03 33
AIR phosphatidylinositol phosphate kinase activity (GO:0016307) 2.89E−03 1.13E−02 4.01E−03 7
AIR protein kinase binding (GO:0019901) 4.57E−03 5.48E−03 1.33E−02 99
AIR purine ribonucleoside triphosphate binding (GO:0035639) 1.51E−02 7.31E−03 2.75E−02 69
AIR ligand-dependent nuclear receptor transcription coactivator activity (GO:0030374) 1.70E−02 2.42E−02 1.04E−02 17
AIR syntaxin-1 binding (GO:0017075) 1.81E−02 1.94E−03 2.90E−02 6
CIE phosphatidylinositol binding (GO:0035091) 4.66E−04 3.22E−02 9.13E−03 30
FSS histone methyltransferase activity (GO:0042054) 7.13E−05 8.36E−05 1.98E−03 18
FSS steroid hormone receptor binding (GO:0035258) 2.11E−04 4.14E−04 9.74E−04 22
FSS protein phosphorylated amino acid binding (GO:0045309) 5.05E−04 4.83E−02 2.36E−02 12
FSS core promoter binding (GO:0001047) 4.51E−03 1.41E−03 2.29E−03 24
FSS protein tyrosine kinase activity (GO:0004713) 8.19E−03 5.03E−03 4.90E−02 36
FSS androgen receptor binding (GO:0050681) 9.99E−03 1.28E−04 3.80E−03 11
FSS regulatory region DNA binding (GO:0000975) 2.16E−02 1.99E−02 2.14E−02 44
FSS methylated histone binding (GO:0035064) 2.46E−02 4.06E−02 4.66E−03 16
FSS histone deacetylase binding (GO:0042826) 2.71E−02 3.67E−03 2.05E−02 19
FSS cadherin binding (GO:0045296) 2.90E−02 2.44E−02 2.62E−02 60
CIE + FSS transmitter-gated ion channel activity (GO:0022824) 3.11E−02 3.23E−02 2.54E−04 12
(B)
AIR ubiquitin-specific protease binding (GO:1990381) 4.96E−02 3.50E−02 2.81E−02 6
CIE GTP binding (GO:0005525) 7.39E−06 9.18E−07 1.96E−03 43
CIE purine ribonucleoside binding (GO:0032550) 1.61E−05 3.97E−06 9.53E−04 45
CIE guanyl ribonucleotide binding (GO:0032561) 6.76E−05 1.31E−05 1.00E−03 46
FSS translation initiation factor activity (GO:0003743) 2.51E−03 4.50E−05 4.00E−02 11
FSS translation factor activity, RNA binding (GO:0008135) 3.24E−03 7.82E−05 3.21E−02 15
CIE + FSS syntaxin binding (GO:0019905) 6.20E−03 1.99E−04 1.40E−02 22
CIE + FSS ubiquitin-protein transferase activity (GO:0004842) 1.83E−02 6.60E−03 2.46E−02 73
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Cluster:  13 − genes: 2 Cluster:  14 − genes: 2
Cluster:  9 − genes: 22 Cluster:  10 − genes: 8 Cluster:  11 − genes: 5 Cluster:  12 − genes: 5
Cluster:  5 − genes: 16 Cluster:  6 − genes: 11 Cluster:  7 − genes: 54 Cluster:  8 − genes: 11




































































































































































































































































Figure 6. Cluster analysis of gene expressions to define temporal and group-wise differences.
Cluster analysis of 292 differentially expressed genes (padj < 0.05) to define temporal and group-wise
differences. These clusters were produced using the degPatterns function on the regularized log
transformation of the normalized counts. Each cluster represents gene expression patterns shared
among differentially expressed genes. Box plots are shown for the expression patterns of each gene
within the group. Circles represent the number of genes in each group.
Neuropsychiatric disorders are recurrent negative states of human well-being affected by genetic
predisposition and environmental factors. Repeated exposure to stressful and harmful environmental
conditions interacts with the genetic factors, shaping neurobiological pathways and subsequent
behavior. Using gene expression measurements as a surrogate for biological systems affected by CTL,
CIE, FSS, and CIE + FSS, the current study suggests multiple systems are affected by chronic ethanol,
chronic stress, and the combination of both experiences (Supplemental Table S1). The identified
affected biological systems were filtered for recurring changes at each of the individual timepoints
but which were also selectively observed in only a single behavioral group (CTL, CIE, FSS, and CIE +
FSS). Canonical molecular-level activity for increased gene expression (Table 1A) demonstrated one
unique result for CIE and CIE+FSS: phosphatidylinositol binding (GO:0035091) and transmitter-gated
ion channel activity (GO:0022824), respectively. Phosphatidylinositol-binding sites, including the
sorting nexin family (e.g., SNX9, SNX13, and SNX17), are important for facilitating intracellular
trafficking and cellular signaling. Transmitter-gated ion channels, such as genes encoding for GABA-A
receptors (GABRA3) and glutamate receptors (GRIA1, GRIK1, and GRIK2), are known molecular sites
of interaction for alcohol [39]; however, persistent gene expression of these ion channels appears
dependent upon the added component of repeated stress. This lasting expression of such ion channels
due to FSS may involve the regulation of nuclear receptor binding (e.g., steroid hormone receptor
binding (GO:0035258)) and epigenetic control (e.g., histone methyltransferase activity (GO:0042054)).
Each of the treatment groups showed consistent evidence for a more limited number of molecular
functions (Table 1B). The coupling of CIE and FSS uniquely downregulates genes involved in syntaxin
binding (GO:0019905) and ubiquitin-protein transferase activity GO:0004842). Attenuated expression
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of syntaxin-binding genes (e.g., SYT4, SYT11, RAB11A, and NAPA) may be a compensatory mechanism
for managing the release of neurotransmitters targeting increased expression of critical ion-channels.
The mammalian central nervous system is a heterogeneous mixture of cell types, including neurons,
oligodendrocytes, astrocytes, and microglia. Each of these CNS cell types expresses a compendium of
genes, characteristic of their biological function for responding to environmental stimuli and regulating
behavior. To identify the cellular systems affected by each of the behavioral treatment groups (CTL, CIE,
FSS, and CIE + FSS), we determined if any of the main CNS cell types were significantly enriched for
differentially expressed genes from each condition (Table 2). With the exception of the nondependent
alcohol drinking, neuronal expression signatures were enriched in both up- and downregulated
genes across treatment groups and timepoints. Microglia- and astrocyte-related gene expression were
increased for only CIE and CIE + FSS animals at the 0-hr timepoint, which may suggest chronic
intermittent ethanol vapor exposure induces a generalized inflammatory state that dissipates over time.
At the 72-h timepoint, all behavioral groups were overrepresented for increased gene expression in both
neurons and astrocytes. Although only a modest number of genes were increased for astrocyte-related
expression at this timepoint, this may indicate a temporal homeostatic relationship between astrocytes
and the neuronal function. Epigenetic and transcriptional reprogramming of cellular responses is a
latent feature of addiction to alcohol and other abused substances [40,41]. As previously mentioned,
CIE+FSS was the only condition to consistently elicit increased expression of genes with recognized
roles in “transmitter-gated ion channel activity” (GO:0022824). This may suggest a concerted effect
of CIE+FSS (i.e., dependence and stress) on receptor-mediated plasticity in the CTX, mediating the
chronic escalation of alcohol consumption observed in this animal model. The current studies suggest
a unique set of genes distinguishing biological differences within the CTX between non-dependent
alcohol consumption (CTL), CIE, FSS, and CIE + FSS.
Table 2. CNS cell-type analysis of differential expressed genes for CTL, CIE, FSS, and CIE + FSS at
time 0 h, 72 h, and 168 h. The four major CNS cell types (neurons, oligodendrocytes, astrocytes, and
microglia) represented by genes with 10-fold expression were evaluated for the overrepresentation of (A)
increased and (B) differentially expressed genes. The number of genes represent the union of significant
genes determined for each behavioral group across the 0-h, 72-h, and 168-h collected timepoints.
Group Cell-Type 000-h 072-h 168-h Number of Genes
(A)
Neurons 1.22E−06 7.53E−23 6.91E−03 113
Oligodendrocytes 5.49E−01 7.23E−01 6.99E−01 3
AIR Astrocytes 3.94E−01 2.00E−03 8.32E−01 34
Microglia 9.79E−01 9.97E−01 4.08E−01 48
Neurons 7.06E−08 7.68E−03 5.53E−14 106
CIE Oligodendrocytes 3.52E−01 8.21E−01 6.39E−01 5
Astrocytes 9.33E−05 2.36E−02 5.06E−01 49
Microglia 1.87E−20 8.67E−06 3.22E−01 140
Neurons 1.25E−32 4.23E−06 1.13E−04 128
FSS Oligodendrocytes 2.68E−01 7.79E−01 1.88E−04 8
Astrocytes 1.02E−01 1.41E−03 4.36E−01 33
Microglia 1.00E+00 7.12E−01 8.16E−01 41
Neurons 2.58E−18 2.17E−08 1.02E−10 141
CIE + FSS Oligodendrocytes 2.81E−02 7.87E−10 8.68E−02 21
Astrocytes 2.57E−05 2.13E−05 8.76E−01 59
Microglia 2.48E−17 2.11E−01 7.06E−01 124
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Table 2. Cont.
Group Cell-Type 000-h 072-h 168-h Number of Genes
(B)
Neurons 3.15E−02 5.73E−02 6.22E−02 55
Oligodendrocytes 7.50E−01 9.08E−04 1.00E+00 9
AIR Astrocytes 3.36E−03 3.48E−01 1.38E−02 33
Microglia 9.49E−01 9.25E−01 8.35E−01 42
Neurons 2.00E−05 7.31E−12 1.61E−03 90
CIE Oligodendrocytes 2.53E−01 5.76E−02 5.16E−01 7
Astrocytes 1.42E−11 2.95E−03 1.42E−03 58
Microglia 9.71E−01 9.74E−01 9.93E−01 46
Neurons 7.33E−03 1.90E−02 4.62E−02 55
FSS Oligodendrocytes 8.86E−01 3.48E−01 6.00E−01 4
Astrocytes 7.93E−02 9.34E−01 9.11E−02 26
Microglia 7.75E−01 9.99E−01 5.56E−02 46
Neurons 1.69E−07 2.81E−10 7.85E−03 80
CIE + FSS Oligodendrocytes 9.64E−02 1.00E+00 1.00E+00 4
Astrocytes 2.31E−13 5.40E−01 2.16E−06 59
Microglia 7.69E−01 9.99E−01 1.96E−01 46
4. Conclusions
Repeated and uncontrolled behavioral disturbances are a significant source of environmental
pressure capable of adversely impacting mental health. Using an animal model of chronic stress
and alcohol dependence, our current studies demonstrate an array of transcriptomic alterations
within the CTX that relate to increased alcohol consumption associated with chronic alcohol (CIE)
exposure, as well as the capacity of stress (FSS) to further enhance elevated drinking in dependent
mice. Assessing time-dependent changes in gene expression reveals both transitory periods of
transcriptional regulation, as well as persistent (long-lasting) gene expression changes associated
with this CIE-stress drinking model. Through a comprehensive evaluation of transcriptome-wide
disruptions in the regulation of gene expression, results from the present study provide a useful
resource for discovering unknown biological contributors to stress-related excessive alcohol drinking
associated with dependence.
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